The clinical effect caused by the studied mutation is similar to those reported for other mutations in the Kir2.1 (e.g., p.D172N) detected in patients affected by SQT3S and/or atrial fibrillation without comorbidity with neuropsychiatric conditions (Xia et al., 2005). The gene discussed is KCNJ2; the disease is atrial fibrillation.